Standards of Specialized Diabetes Care / Edited by Dedov I.I., Shestakova M.V., Mayorov A.Yu. 11th Edition

Author:

Dedov I.1ORCID,Shestakova M.1ORCID,Mayorov A.2ORCID,Mokrysheva N.1ORCID,Andreeva E. 3ORCID,Bezlepkina O.1ORCID,Peterkova V.1ORCID,Artemova E.1ORCID,Bardiugov P.1ORCID,Beshlieva D.1,Bondarenko O.1ORCID,Burumkulova F.4ORCID,Vikulova O.1ORCID,Volevodz N.1ORCID,Galstyan G.1ORCID,Gomova I.1,Grigoryan O.1ORCID,Dzhemilova Z.1ORCID,Ibragimova L.1ORCID,Kalashnikov V.1ORCID,Kononenko I.1ORCID,Kuraeva T.1ORCID,Laptev D.1ORCID,Lipatov D.1ORCID,Melnikova O.1ORCID,Mikhina M.1ORCID,Michurova M.1ORCID,Motovilin O.1ORCID,Nikonova T.1ORCID,Rozhivanov R.1ORCID,Smirnova O.1ORCID,Starostina E.5ORCID,Surkova E.6ORCID,Sukhareva O.1ORCID,Tiselko A.7ORCID,Tokmakova A.1ORCID,Shamkhalova M.1ORCID,Shestakova E.1ORCID,Jarek-Martynowa I.1ORCID,Yaroslavceva M.1ORCID

Affiliation:

1. Endocrinology Research Centre of the Ministry of Health of the Russian Federation

2. Endocrinology Research Centre of the Ministry of Health of the Russian Federation

3. Endocrinology Research Centre of the Ministry of Health of the Russian Federation; A.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of the Russian Federation

4. Moscow Regional Research Institute of Obstetrics and Gynecology; M.F. Vladimirsky Moscow Regional Clinical and Research Institute of the Ministry of Health of Moscow region

5. M.F. Vladimirsky Moscow Regional Clinical and Research Institute of the Ministry of Health of Moscow region

6. I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)

7. FSBI «The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott»

Abstract

Dear Colleagues!We are glad to present the 11th Edition of the Standards of Specialized Diabetes Care. These evidence-based guidelines were designed to standardize and facilitate diabetes care in all regions of the Russian Federation.The Standards are updated on the regular basis to incorporate new data and relevant recommendations from national and international clinical societies, including World Health Organization Guidelines (WHO), International Diabetes Federation (IDF), European Association for the Study of Diabetes (EASD), American Diabetes Association (ADA), American Association of Clinical Endocrinologists (AACE), International Society for Pediatric and Adolescent Diabetes (ISPAD) and Russian Association of Endocrinologists (RAE). Current edition of the “Standards” also integrates results of completed randomized clinical trials, as well as findings from the national studies of diabetes mellitus (DM), conducted in close partnership with a number of Russian hospitals.Latest data indicates that prevalence of DM in the world increased during the last decade more than two-fold, reaching some 537 million patients by the end of 2021. According to the current estimation by the International Diabetes Federation, 643 million patients will be suffering from DM by 2030 and 783 million by 2045.Like many other countries, Russian Federation experiences a sharp rise in the prevalence of DM. According to Russian Federal Diabetes Register, there are at least 4 962 762 patients with DM in this country on 01.01.2023 (3,42% of population) with 92,3% (4 581 990) – Type 2 DM, 5,6% (277 092) – Type 1 DM and 2,1% (103 680) – other types of DM, including 8 758 women with gestational DM. However, these results underestimate real quantity of patients, because they consider only registered cases. Results of Russian epidemiological study (NATION) confirmed that 54% of patients with Type 2 DM are undiagnosed. So real number of patients with DM in Russia is 11-12 million patients (about 7% of population). This is a great long-term problem, because a lot of patients are not diagnosed, so they don’t receive any treatment and have high risk of vascular complications.Severe consequences of the global pandemic of DM include its vascular complications: nephropathy, retinopathy, coronary, cerebral and peripheral vascular disease. These conditions are responsible for the majority of cases of diabetes-related disability and death.In accordance with the Federal Law № 489-FZ of 25.12.2018 medical care should be provided on the basis of the clinical recommendations. Therefore, clinical recommendations posted in the rubricator of the Ministry of Health of the Russian Federation (https://cr.minzdrav.gov.ru) being the priority.This edition of the Algorithms for Specialized Care for Patients with Diabetes Mellitus contains the main information from the clinical guidelines for the management of diabetes mellitus in adults and children (“Type 1 Diabetes in Children (2022)”, “Type 1 Diabetes in Adults (2022)”, “Type 2 diabetes mellitus in children (2021)”, “Type 2 diabetes mellitus in adults (2022)”), as well as the updated data.New information has been added about indications for using of antihyperglycemic drugs and their instructional restrictions; algorithm of treatment of type 2 diabetes mellitus has been updated; clarifications have been made on the range of glycemic control in pregnant women; information on the treatment of diabetic complications and the management of pediatric patients has been added. In 2023, Russian diabetology suffered an unbearable loss - Alexander Yuryevich Mayorov, who was the executive editor of the previous issues and an active participant of the work on all the previous editions of “Algorithms” from the moment they were founded, passed away. This publication is dedicated to the memory of Alexander Yuryevich, who was an example of the service to patients and medicine, a friend, teacher, mentor, generously sharing his knowledge and the sample of the execution of the medical duty to all of us. On behalf of the Working Group

Publisher

Endocrinology Research Centre

Reference54 articles.

1. Dedov I.I., Mel'nichenko G.A., Shestakova M.V., i dr. Natsional'nye klinicheskie rekomendatsii po lecheniyu morbidnogo ozhireniya u vzroslykh. 3-ii peresmotr (lechenie morbidnogo ozhireniya u vzroslykh). // Ozhirenie i metabolizm. — 2018. — T.15. — № 1 — S.53-70. [Dedov II, Mel’nichenko GA, Shestakova MV, et al. Russian national clinical recommendations for morbid obesity treatment in adults. 3rd revision (Morbid obesity treatment in adults). Obesity and metabolism. 2018;15(1):53-70.] doi: 10.14341/OMET2018153-70

2. Dedov I.I., Shestakova M.V., Maiorov A.Yu., i dr. «Algoritmy spetsializirovannoi meditsinskoi pomoshchi bol'nym sakharnym diabetom» (10-i vypusk). Pod redaktsiei I.I. Dedova, M.V. Shestakovoi, A.Yu. Maiorova. // Cakharnyi diabet. – 2021. –№1S – C. 1-148. [Dedov II, Shestakova MV, Mayorov AY, et al. Standards of specialized diabetes care. Edited by Dedov II, Shestakova MV, Mayorov AY (10th edition). Diabetes mellitus. 2021;24(1S):1-144.] doi.org/10.14341/DM12802

3. Dedov I.I., Shestakova M.V., Maiorov A.Yu., i dr. Klinicheskie rekomendatsii. Sakharnyi diabet 1 tipa u vzroslykh (2022g). Dostupno v rubrikatore klinicheskikh rekomendatsii MZ RF.

4. Dedov I.I., Shestakova M.V., Maiorov A.Yu., i dr. Klinicheskie rekomendatsii. Sakharnyi diabet 2 tipa u vzroslykh (2022g). Dostupno v rubrikatore klinicheskikh rekomendatsii MZ RF.

5. Maiorov A.Yu., Mel'nikova O.G., Koteshkova O.M., Misnikova I.V., Chernikova N.A. Tekhnika in\"ektsii i infuzii pri lechenii sakharnogo diabeta. Metodicheskoe rukovodstvo. OOO «ARTINFO», Moskva, 2018 – 64 s. [Mayorov AY, Melnikova OG, Koteshkova OM, Misnikoba IV, Chernikova NA. Tekhnika in’ektsiy I infuzii pri lechenii sakharnogo diabeta. Metodicheskoe rukovodstvo. OOO “ARTINFO”, Moscow, 2018 -64 p.].

Cited by 56 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3